Cost–Utility and Budget Impact Analyses of Oral Chemotherapy for Stage III Colorectal Cancer: Real-World Evidence after Policy Implementation in Thailand

Cost–Utility and Budget Impact Analyses of Oral Chemotherapy for Stage III Colorectal Cancer: Real-World Evidence after Policy Implementation in Thailand

This study conducted a cost–utility analysis and a budget impact analysis (BIA) of outpatient oral chemotherapy versus inpatient intravenous chemotherapy for stage III colorectal cancer (CRC) in Thailand. A Markov model was constructed to estimate the lifetime cost and health outcomes based on a soc...

Full description

Bibliographic Details
Main Authors: Pochamana Phisalprapa, Chayanis Kositamongkol, Krittiya Korphaisarn, Charuwan Akewanlop, Vichien Srimuninnimit, Siripen Supakankunti, Natnasak Apiraksattayakul, Nathorn Chaiyakunapruk
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Cancers
Subjects:
budget impact analysis
capecitabine
colorectal cancer stage III
cost–utility analysis
oral chemotherapy
Online Access:https://www.mdpi.com/2072-6694/15/20/4930

Internet

https://www.mdpi.com/2072-6694/15/20/4930

Similar Items